EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defective Trophoblast Differentiation, Endothelial Dysfunction, and Immune Dysregulation in Preeclampsia Coalesce on a Placental VGLL3-Centered Gene Network

Olesya Plazyo iD, Laura B Chopp iD, Rishyanth Peela, Kelly Young, Haihan Zhang iD, Rachael Bogle iD, Ashley Hesson iD, Elizabeth S Langen iD, Ingrid L Bergin iD, Li-Jyun Syu, Jake Erba, Joseph Kirma und 13 weitere

Circulation · 02.06.2026 · 153 (22) · 1743-1760

DOI: 10.1161/circulationaha.125.076218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.06.2026. Verfasst von Olesya Plazyo und 24 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology (O.P., L.B.C., R.P., K.Y., H.Z., R.B., L.-J.S., J.E., J.K., P.D., L.Z., M.K.S., J.M.K., A.C.B., A.A.D., L.C.T., J.E.G.), U…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Trophoblasts, Transcription Factors, Cell Differentiation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health risks for both mother and offspring. While the etiology remains unclear, preeclampsia has been linked to both autoimmunity and the timing of menarche. METHODS: Through human single-cell and spatial analyses, coupled with in vitro, in vivo, and ex vivo models, we demonstrate that VGLL3 (Vestigial-like family member 3), a transcription coregulator in the Hippo pathway, is upregulated in preeclamptic placentas. RESULTS: VGLL3 promotes immune activation, impairs trophoblast differentiation, and induces endothelial dysfunction, all of which contribute to pregnancy-related hypertension, fetal growth restriction, and offspring mortality. Our data reveal that VGLL3 acts upstream of preeclampsia-associated processes, including the production of sFLT1 (soluble fms-like tyrosine kinase 1), a key biomarker of the disease. Notably, targeting VGLL3, either by genetic deletion in mouse placentas or through therapeutic inhibition in human placentas, protects against preeclampsia and alleviates disease pathology. CONCLUSIONS: These findings position VGLL3 as a promising novel therapeutic target for preeclampsia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaTrophoblastsTranscription FactorsCell DifferentiationPlacentaEndothelium, VascularFemalePregnancyHumansAnimalsMice

Stichwörter der Autor:innen

Hippo signaling pathwayendothelium, vasculargenes, regulatorhypertension, pregnancy inducedimmunity, activepre-eclampsiatrophoblasts

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Departments of Dermatology (O.P., L.B.C., R.P., K.Y., H.Z., R.B., L.-J.S., J.E., J.K., P.D., L.Z., M.K.S., J.M.K., A.C.B., A.A.D., L.C.T., J.E.G.), University of Michigan, Ann Arbor, MI.
  • Obstetrics(and)Gynecology (A.H., E.S.L.), University of Michigan, Ann Arbor, MI.
  • Unit for Laboratory Animal Medicine (I.L.B.), University of Michigan, Ann Arbor, MI.
  • Cell(and)Developmental Biology (L.-J.S., A.A.D.), University of Michigan, Ann Arbor, MI.
  • Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (W.R.S.).
  • Surgery (K.A.G.), University of Michigan, Ann Arbor, MI.

ORCID-Profile: Olesya Plazyo, Laura B Chopp, Haihan Zhang, Rachael Bogle, Ashley Hesson, Elizabeth S Langen, Ingrid L Bergin, Poulami Dey, Mrinal K Sarkar, Katherine A Gallagher, Nicole L Ward, Kanakadurga Singer, J Michelle Kahlenberg, Allison C Billi, Andrzej A Dlugosz, Santhi K Ganesh, Johann E Gudjonsson

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Plazyo, O., Chopp, L. B., Peela, R., Young, K., Zhang, H., Bogle, R., Hesson, A., Langen, E. S., Bergin, I. L., Syu, L. J., Erba, J., Kirma, J., Dey, P., Zhang, L., Sarkar, M. K., Swindell, W. R., Gallagher, K. A., Ward, N. L., Singer, K., …, & Gudjonsson, J. E. (2026). Defective Trophoblast Differentiation, Endothelial Dysfunction, and Immune Dysregulation in Preeclampsia Coalesce on a Placental VGLL3-Centered Gene Network. Circulation, 153(22), 1743-1760. https://doi.org/10.1161/circulationaha.125.076218

Vancouver

Plazyo O, Chopp LB, Peela R, Young K, Zhang H, Bogle R, et al. Defective Trophoblast Differentiation, Endothelial Dysfunction, and Immune Dysregulation in Preeclampsia Coalesce on a Placental VGLL3-Centered Gene Network. Circulation. 2026;153(22):1743-1760. doi:10.1161/circulationaha.125.076218

BibTeX
@article{Plazyo2026,
  author = {Plazyo, Olesya and Chopp, Laura B and Peela, Rishyanth and Young, Kelly and Zhang, Haihan and Bogle, Rachael and Hesson, Ashley and Langen, Elizabeth S and Bergin, Ingrid L and Syu, Li-Jyun and Erba, Jake and Kirma, Joseph and Dey, Poulami and Zhang, Lin and Sarkar, Mrinal K and Swindell, William R and Gallagher, Katherine A and Ward, Nicole L and Singer, Kanakadurga and Kahlenberg, J Michelle and Billi, Allison C and Dlugosz, Andrzej A and Ganesh, Santhi K and Tsoi, Lam C and Gudjonsson, Johann E},
  title = {Defective Trophoblast Differentiation, Endothelial Dysfunction, and Immune Dysregulation in Preeclampsia Coalesce on a Placental VGLL3-Centered Gene Network},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {22},
  pages = {1743--1760},
  doi = {10.1161/circulationaha.125.076218}
}
Kostenlos starten →